Literature DB >> 3316472

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

W J Murphy1, V Kumar, M Bennett.   

Abstract

Lethally irradiated C.B-17 +/+, C.B-17 scid/scid (severe combined immunodeficiency, SCID), BALB/c-nu/nu (nude), and C57BL/6 (B6) mice were challenged with H-2-homozygous or H-2-heterozygous totally allogeneic bone marrow cell (BMC) grafts. Some of the irradiated mice were immunized simultaneously with large numbers of irradiated marrow and spleen cells syngeneic with the viable BMC transferred. Irradiated SCID and nude mice, devoid of T cells but with normal NK cell function, were able to reject H-2-homozygous BMC grafts within 4 d. However, they were unable to reject H-2-heterozygous BMC allografts by 7 d even if they were immunized. B6 and C.B-17 +/+ mice were able to reject H-2 heterozygous BMC allografts by 7-8 d, but not as early as 4 d, if they were immunized. The rejection of H-2-homozygous BMC on day 4 was inhibited by administration of anti-NK-1.1 antibodies, but not by anti-Lyt-2 antibodies. Conversely, the rejection of H-2-heterozygous allogeneic BMC on day 8 was prevented by anti-Lyt-2 but not by anti-NK-1.1 antibodies. The data indicate that both NK cells and Lyt-2+ T cells can mediate rejection of allogeneic BMC acutely, even after exposure of mice to lethal doses of ionizing irradiation. NK cells appear to recognize Hemopoietic histocompatibility (Hh) antigens on H-2 homozygous stem cells. The inability of SCID and nude mice to reject H-2 heterozygous totally allogeneic BMC indicate that NK cells do not survey donor marrow cells for self H-2 antigens and reject those cells that express nonself H-2 antigens. The T cells presumably recognize conventional H-2 antigens (probably class I) under these conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316472      PMCID: PMC2189655          DOI: 10.1084/jem.166.5.1499

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts.

Authors:  R Kiessling; P S Hochman; O Haller; G M Shearer; H Wigzell; G Cudkowicz
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

2.  Rejection of marrow allografts: importance of H-2 homozygosity of donor cells.

Authors:  M Bennett
Journal:  Transplantation       Date:  1972-09       Impact factor: 4.939

Review 3.  Analysis of deficient colony-forming performance of bone marrow cells in non-syngeneic cell milieu--the impact of non-immune interactions on the behaviour of pluripotent stem cells and the role of H-2 gene products.

Authors:  A Lengerová; V Matousek; V Zelený
Journal:  Transplant Rev       Date:  1973

4.  Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro.

Authors:  M Bennett; G Cudkowicz; R S Foster; D Metcalf
Journal:  J Cell Physiol       Date:  1968-06       Impact factor: 6.384

Review 5.  Mechanisms of early allogeneic marrow graft rejection.

Authors:  H von Melchner; P F Bartlett
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  Cellular basis of the immunohematologic defects observed in short-term semiallogeneic B6C3F1 -- C3H chimeras: evidence for host-versus-graft reaction initiated by radioresistant T cells.

Authors:  S Aizawa; T Sado; H Kamisaku; E Kubo
Journal:  Cell Immunol       Date:  1980-11       Impact factor: 4.868

7.  Natural killer cells kill tumour cells at a given stage of differentiation.

Authors:  M Gidlund; A Orn; P K Pattengale; M Jansson; H Wigzell; K Nilsson
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

Review 8.  Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.

Authors:  P C Doherty; B B Knowles; P J Wettstein
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

9.  Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

10.  Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

View more
  50 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  NKG2D in NK and T cell-mediated immunity.

Authors:  Kouetsu Ogasawara; Lewis L Lanier
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

3.  IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses.

Authors:  Hideaki Obara; Kazuhito Nagasaki; Christine L Hsieh; Yasuhiro Ogura; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

4.  Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells.

Authors:  Jakub Tolar; Matthew J O'shaughnessy; Angela Panoskaltsis-Mortari; Ron T McElmurry; Scott Bell; Megan Riddle; R Scott McIvor; Stephen R Yant; Mark A Kay; Diane Krause; Catherine M Verfaillie; Bruce R Blazar
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

5.  Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT.

Authors:  Alwi M Shatry; Derry C Roopenian; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2007-03       Impact factor: 5.742

6.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Authors:  Stephanie B Tsai; Hongtao Liu; Tsiporah Shore; Yun Fan; Michael Bishop; Melissa M Cushing; Usama Gergis; Lucy Godley; Justin Kline; Richard A Larson; Guadalupe Martinez; Sebastian Mayer; Olatoyosi Odenike; Wendy Stock; Amittha Wickrema; Koen van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-19       Impact factor: 5.742

7.  Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye).

Authors:  David H Raulet
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

Review 8.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

Review 9.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

Review 10.  Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.